Daniel E. Frigo: Lipid Metabolism as a Critical Regulator of Cancer Progression and a Promising Therapeutic Frontier
Daniel E. Frigo/LinkedIn

Daniel E. Frigo: Lipid Metabolism as a Critical Regulator of Cancer Progression and a Promising Therapeutic Frontier

Daniel E. Frigo, Professor, Deputy Chair and Scientific Director of Research at MD Anderson Cancer Center, shared a post on LinkedIn:

“Lipid metabolism is rapidly emerging as a critical regulator of cancer progression and a promising therapeutic frontier.

In our new Trends in Cancer review, ‘Lipids grease the chain of cancer progression,’ we synthesize current insights into fatty acid synthesis and transport, lipid droplets, oxidation, ROS dynamics, and ferroptosis—pathways with potential clinical impact.

A collaborative effort led by Joe Rupert and Nikki Cao, in partnership with Misha Kolonin’s lab.

Title: Lipids grease the chain of cancer progression

Authors: Joseph Rupert, Pham Hong Anh Cao, Daniel E. Frigo, Mikhail G. Kolonin

Read the Full Article in Trends in Cancer.

Daniel E. Frigo: Lipid Metabolism as a Critical Regulator of Cancer Progression and a Promising Therapeutic Frontier

More posts featuring Daniel E. Frigo.